MA56525B1 - Dérivés de benzisoxazole sulfonamide - Google Patents
Dérivés de benzisoxazole sulfonamideInfo
- Publication number
- MA56525B1 MA56525B1 MA56525A MA56525A MA56525B1 MA 56525 B1 MA56525 B1 MA 56525B1 MA 56525 A MA56525 A MA 56525A MA 56525 A MA56525 A MA 56525A MA 56525 B1 MA56525 B1 MA 56525B1
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- sulfonamide derivatives
- patients
- cell growth
- abnormal cell
- Prior art date
Links
- OIFAKIJHBGJKLD-UHFFFAOYSA-N 1,2-benzoxazole-3-sulfonamide Chemical class C1=CC=C2C(S(=O)(=O)N)=NOC2=C1 OIFAKIJHBGJKLD-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000002159 abnormal effect Effects 0.000 abstract 2
- 230000010261 cell growth Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La présente invention concerne des composés de formule (i) ou des sels pharmaceutiquement acceptables de ceux-ci, dans laquelle le cycle a, r1-r8 et n ont la signification indiquée dans la description. Les nouveaux dérivés de benzisoxazole sulfonamide sont utiles dans le traitement d'une croissance cellulaire anormale, telle que le cancer, chez des patients. D'autres modes de réalisation concernent des compositions pharmaceutiques contenant les composés et des méthodes d'utilisation des composés et des compositions dans le traitement d'une croissance cellulaire anormale chez des patients.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962863199P | 2019-06-18 | 2019-06-18 | |
| PCT/IB2020/055589 WO2020254946A1 (fr) | 2019-06-18 | 2020-06-16 | Dérivés de benzisoxazole sulfonamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA56525A MA56525A (fr) | 2022-04-27 |
| MA56525B1 true MA56525B1 (fr) | 2024-02-29 |
Family
ID=80633360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA56525A MA56525B1 (fr) | 2019-06-18 | 2020-06-16 | Dérivés de benzisoxazole sulfonamide |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR119747A1 (fr) |
| MA (1) | MA56525B1 (fr) |
-
2020
- 2020-06-16 MA MA56525A patent/MA56525B1/fr unknown
- 2020-06-17 AR ARP200101705A patent/AR119747A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR119747A1 (es) | 2022-01-05 |
| MA56525A (fr) | 2022-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA67365B1 (fr) | Dérivés de benzisoxazole sulfonamide | |
| MA54327B1 (fr) | Inhibiteurs de kras g12c | |
| TN2014000115A1 (fr) | Derives de pyrrolopyrimidines et de purines | |
| MA56883B1 (fr) | Dérivés de 2-hydroxycycloalcane-1-carbamoyle | |
| MA39043A1 (fr) | Dérivés de purine substitués en positions 2 et 6, et leur utilisation dans le traitement des désordres prolifératifs | |
| MA27559A1 (fr) | Nouveaux derives de fluorglycoside aromatiques, produits pharmaceutiques contenant ces composes et leur utilisation | |
| MA27560A1 (fr) | Nouveaux derives de fluorglycoside heterocycliques, produits pharmaceutiques contenant ces composes et leur utilisation | |
| TNSN01091A1 (fr) | Derives bicycliques nouveaux, compositions les contenant et leur utilisation pour le traitement d'une croissance cellulaire anormale | |
| TN2009000428A1 (fr) | Derives de sulfonylamides destines au traitement d'une croissance cellulaire anormale | |
| MA30403B1 (fr) | Derives d'acides cycloalkylamines et leurs compositions pharmaceutiques | |
| MA54653B1 (fr) | Modulateurs du récepteur de cxcr7 pipéridine | |
| TN2009000544A1 (fr) | Derives de benzimidazole | |
| TNSN00228A1 (fr) | Derives de benzimidazole nouveaux, et compositions les contenant | |
| MA28747B1 (fr) | Dérivés de pyridine | |
| MA31419B1 (fr) | Derives de pyridine | |
| MA29926B1 (fr) | Derives de pyrazine | |
| TNSN08270A1 (fr) | Dérivés pyrimidiques destinés à traiter une croissance cellulaire anormale | |
| MA31761B1 (fr) | Nouveaux inhibiteurs de seh et leur utilisation | |
| MA31894B1 (fr) | Composes organiques | |
| MA31979B1 (fr) | (cyclopropylphenyl) phenyloxamides, leur procede de production et leur utilisation comme medicament | |
| MA31710B1 (fr) | (carboxylalkylenephenyl)phényloxamides, procédés pour la production de ceux-ci et utilisation de ceux-ci en tant que medicament | |
| MA24729A1 (fr) | Macrolides nouveaux. | |
| MA30911B1 (fr) | Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine | |
| MA27568A1 (fr) | Derives de pyrrolopyrimidine | |
| MA31574B1 (fr) | Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf |